| Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ... Nature communications 10 (1), 1-20, 2019 | 116 | 2019 |
| Quantitative analysis of endogenous compounds R Thakare, YS Chhonker, N Gautam, JA Alamoudi, Y Alnouti Journal of pharmaceutical and biomedical analysis 128, 426-437, 2016 | 101 | 2016 |
| Pharmacodynamic and antiretroviral activities of combination nanoformulated antiretrovirals in HIV-1–infected human peripheral blood lymphocyte–reconstituted mice U Roy, JE McMillan, Y Alnouti, N Gautum, N Smith, S Balkundi, P Dash, ... The Journal of infectious diseases 206 (10), 1577-1588, 2012 | 65 | 2012 |
| Preclinical pharmacokinetics and tissue distribution of long-acting nanoformulated antiretroviral therapy N Gautam, U Roy, S Balkundi, P Puligujja, D Guo, N Smith, XM Liu, ... Antimicrobial agents and chemotherapy 57 (7), 3110-3120, 2013 | 60 | 2013 |
| Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells GD Kanmogne, S Singh, U Roy, X Liu, JE McMillan, S Gorantla, ... International journal of nanomedicine 7, 2373, 2012 | 60 | 2012 |
| Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles T Zhou, H Su, P Dash, Z Lin, BLD Shetty, T Kocher, A Szlachetka, ... Biomaterials 151, 53-65, 2018 | 51 | 2018 |
| Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disorders P Coiro, R Padmashri, A Suresh, E Spartz, G Pendyala, S Chou, Y Jung, ... Brain, behavior, and immunity 50, 249-258, 2015 | 48 | 2015 |
| Creation of a long-acting nanoformulated dolutegravir B Sillman, AN Bade, PK Dash, B Bhargavan, T Kocher, S Mathews, H Su, ... Nature communications 9 (1), 1-14, 2018 | 47 | 2018 |
| Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs DP Gnanadhas, PK Dash, B Sillman, AN Bade, Z Lin, DL Palandri, ... The Journal of clinical investigation 127 (3), 857-873, 2017 | 37 | 2017 |
| Development and characterization of a long-acting nanoformulated abacavir prodrug D Singh, JE McMillan, J Hilaire, N Gautam, D Palandri, Y Alnouti, ... Nanomedicine 11 (15), 1913-1927, 2016 | 37 | 2016 |
| Creation of a long-acting nanoformulated 2′, 3′-dideoxy-3′-thiacytidine D Guo, T Zhou, M Araínga, D Palandri, N Gautam, T Bronich, Y Alnouti, ... Journal of acquired immune deficiency syndromes (1999) 74 (3), e75, 2017 | 36 | 2017 |
| Urinary bile acids as biomarkers for liver diseases I. Stability of the baseline profile in healthy subjects SPR Bathena, R Thakare, N Gautam, S Mukherjee, M Olivera, J Meza, ... Toxicological Sciences 143 (2), 296-307, 2015 | 35 | 2015 |
| UPLC–MS/MS quantification of nanoformulated ritonavir, indinavir, atazanavir, and efavirenz in mouse serum and tissues J Huang, N Gautam, SPR Bathena, U Roy, JE McMillan, HE Gendelman, ... Journal of Chromatography B 879 (23), 2332-2338, 2011 | 35 | 2011 |
| Peripherally cross-linking the shell of core-shell polymer micelles decreases premature release of physically loaded combretastatin A4 in whole blood and increases its mean … RR Wakaskar, SPR Bathena, SB Tallapaka, VV Ambardekar, N Gautam, ... Pharmaceutical research 32 (3), 1028-1044, 2015 | 32 | 2015 |
| Targeting the NF-κB and mTOR pathways with a quinoxaline urea analog that inhibits IKKβ for pancreas cancer therapy P Radhakrishnan, VC Bryant, EC Blowers, RN Rajule, N Gautam, ... Clinical Cancer Research 19 (8), 2025-2035, 2013 | 30 | 2013 |
| Species differences in bile acids I. Plasma and urine bile acid composition R Thakare, JA Alamoudi, N Gautam, AD Rodrigues, Y Alnouti Journal of Applied Toxicology 38 (10), 1323-1335, 2018 | 27 | 2018 |
| Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients SPR Bathena, R Thakare, N Gautam, S Mukherjee, M Olivera, J Meza, ... Toxicological Sciences 143 (2), 308-318, 2015 | 23 | 2015 |
| Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations N Gautam, P Puligujja, S Balkundi, R Thakare, XM Liu, HS Fox, ... Antimicrobial agents and chemotherapy 58 (12), 7510-7519, 2014 | 22 | 2014 |
| Pharmacokinetics of a long-acting nanoformulated dolutegravir prodrug in rhesus macaques JE McMillan, A Szlachetka, L Slack, B Sillman, B Lamberty, B Morsey, ... Antimicrobial agents and chemotherapy 62 (1), 2018 | 21 | 2018 |
| Simultaneous LC–MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF R Thakare, YS Chhonker, N Gautam, A Nelson, R Casaburi, G Criner, ... Biomedical Chromatography 32 (3), e4102, 2018 | 19 | 2018 |
